Does DIGOXIN Cause Electrocardiogram qt prolonged? 128 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Electrocardiogram qt prolonged have been filed in association with DIGOXIN (Digoxin). This represents 1.7% of all adverse event reports for DIGOXIN.
128
Reports of Electrocardiogram qt prolonged with DIGOXIN
1.7%
of all DIGOXIN reports
8
Deaths
87
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From DIGOXIN?
Of the 128 reports, 8 (6.3%) resulted in death, 87 (68.0%) required hospitalization, and 46 (35.9%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIGOXIN. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does DIGOXIN Cause?
Toxicity to various agents (1,371)
Bradycardia (896)
Dyspnoea (762)
Nausea (762)
Vomiting (715)
Acute kidney injury (708)
Fatigue (638)
Dizziness (616)
Diarrhoea (607)
Drug ineffective (568)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which DIGOXIN Alternatives Have Lower Electrocardiogram qt prolonged Risk?
DIGOXIN vs DIHYDRALAZINE
DIGOXIN vs DIHYDROCODEINE
DIGOXIN vs DIHYDROERGOTAMINE
DIGOXIN vs DILANTIN
DIGOXIN vs DILANTIN-125